Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
Subscribe To Our Newsletter & Stay Updated
